The spectrum of renal thrombotic microangiopathy in lupus nephritis

Table 1 General data of patients combined with renal TMA and lupus nephritis

No.	Age (years)	Clinical diagnosis	Pathological types	CFH (μg/ml)	ACL	Anti-β2GP-1	ADAMTS-13 Activity (%)	C4d deposition on vascular wall
1	25	LN	IV-G(A/C)	386.0	-	-	88	-
2	38	LN	IV-G(A/C)	670.2	-	-	83	++
3	34	LN	IV-G(A)	166.8	-	-	70	+
4	45	LN+MHT	IV-G(A/C)	694.8	-	-	68	-
5	28	LN	IV-G(A/C)	298.8	-	-	94	+
6	43	LN	IV-G(A)+V	642.8	-	-	75	-
7	26	LN+Scleroderma	IV-G(A)	136.0	-	-	74	+
8	26	LN	IV-G(A)+V	112.8	-	-	95	-
9	23	LN	IV-G(A)+V	385.4	-	-	91	+
10	27	LN+TTP-HUS	IV-G(A/C)	146.0	-	-	97	+
11	32	LN	III(A/C)+V	467.6	-	-	95	+
12	38	LN+MHT	IV-G(A/C)	251.6	-	-	98	-
13	20	LN	IV-G(A)	362.4	-	-	98	-
14	31	LN	IV-G(A)	551.2	-	-	71	-
15	25	LN	IV-G(A)	567.4	-	-	85	+
16	19	LN	IV-G(A)	620.4	-	-	98	+
17	34	LN+TTP-HUS	IV-G(A)	365.6	-	-	89	-
18	19	LN	IV-S(A)	457.0	-	-	89	-
19	31	LN	IV-G(A)	491.4	-	-	97	-
20	18	LN+APS	IV-G(A)+V	162.0	+	-	45	+
21	30	LN+APS	V	707.2	-	+	98	+
22	43	LN	III(A/C)+V	498.8	-	-	96	+
23	24	LN	IV-G(A/C)	222.4	-	-	96	+
24	35	LN	IV-G(A/C)	540.0	-	-	99	-
25	40	LN	IV-G(A/C)	117.8	-	-	98	-
26	21	LN	III	201.2	-	-	63	+
27	38	LN	IV-G(A)	672.6	-	-	88	+
28	52	LN	IV-G(A/C)	131.0	-	-	96	-
29	37	LN	V	340.0	-	-	32	-
30	27	LN	IV-G(A)	124.4	-	-	95	-
31	18	LN	IV-G(A/C)	492.8	-	-	95	-
32	15	LN	IV-G(A)	221.2	-	-	97	++
33	33	LN	IV-G(A)	374.0	-	-	80	+
34	15	LN	IV-G(A)	407.2	-	-	68	+
35	40	LN	V	434.2	-	-	96	-
36	20	LN	IV-G(A)	627.6	-	-	97	+

Note: The normal range of serum CFH was 561.3 ± 179.7 (381.6 to 741.0) μg/ml. The normal range of ADAMTS-13 activity was 95% (42% to 99%). Abbreviations: APS, anti-phospholipid syndrome; LN, lupus nephritis; MHT, malignant hypertension; TTP-HUS, thrombotic thrombocytopenic purpura-hemolytic uremic syndrome

ISSN: 1478-6362